* Aravive Inc is expected to show a fall in quarterly revenue when it reports results on August 9 (estimated).
* The Houston Texas-based company is expected to report a 79.9% decrease in revenue to $325 thousand from $1.62 million a year ago, according to the mean estimate from 4 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Aravive Inc is for a loss of 28 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Aravive Inc is $9.5, above its last closing price of $0.25.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.32 -0.32 -0.66 Missed -107.9
Dec. 31 2023 -0.17 -0.30 -0.46 Missed -53.3
Sep. 30 2022 -0.64 -0.64 -0.51 Beat 20.1
Jun. 30 2022 -0.68 -0.59 -0.61 Missed -3
Mar. -0.54 -0.53 -0.62 Missed -15.9
31 2022
Dec. 31 2021 -0.60 -0.62 Missed -3
Sep. 30 2021 -0.47 -0.46 -0.53 Missed -14.6
Jun. 30 2021 -0.38 -0.38 -0.35 Beat 8.9
This summary was machine generated August 7 at 18:33 GMT. All figures in US dollars unless otherwise stated.
Comments